To investigate the varying response of the pilosebaceous unit to androgens functional studies were performed on the effects of testosterone and 5α-dihydrotestosterone on cultured human sebocytes derived from different skin regions. In addition, the effect of spironolactone on the proliferation of androgen-stimulated human sebocytes derived from facial skin was evaluated. Testosterone (1O-11 to 10-5M), 5α-dihydrotestosterone (10-11 to 10-5M) and spironolactone (10-12 to 10-7M) were added for 10 days as single substances or in combinations to human sebocytes in secondary culture maintained in a serum-free medium. Cell proliferation was assessed using a fluorometric assay. Intracellular lipids were extracted from sebocytes treated with androgens (10-7M) for 10 days after con-fluency. Testosterone inhibited the proliferation of sebocytes derived from the legs with a 50%-inhibitory concentration at 10-5M and induced a 50% decrease of intracellular lipids. In contrast, 5 α-dihydro testosterone stimulated the activity of leg sebocytes with a 50% increase of proliferation at 10-5M, and a 175% increase of intracellular lipids. On the other hand, the proliferation of facial sebocytes was significantly stimulated by testosterone with a 50%-stimulatory concentration at 10-6 to 10-5M and mostly by 5α-dihydrotestosterone with a 50% enhancement at 10-8 to 10-7M. Spironolactone inhibited the proliferation of facial sebocytes in a dose-dependent manner with a 25%-inhibitory concentration at 10-9M. Simultaneous treatment of facial sebocytes with spironolactone and testosterone or 5α-dihydrotestosterone resulted in decreased proliferation when compared to the growth obtained under androgens alone. Moreover, spironolactone at 10-7M neutralized the stimulatory activity of 5α-dihydrotestos-terone at all concentrations tested. In contrast to previous reports of no androgen effect on human dermal papilla cells in culture, our results show a specialized response of human sebocytes to androgens dependent on the localization of the sebaceous glands. The direct inhibition of sebocyte proliferation by spironolactone and its antagonistic activity to androgens at the cellular level are indicative of a receptor-monitored effect.

Keywords:
Human sebocytes, Cultured cells, Facial skin, Leg skin, Proliferation, Intracellular lipids, Testosterone, 5α-Dihydrotestosterone, Spironolactone
This content is only available via PDF.
© 1994 S. Karger AG, Basel
1994
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.